SDHB and paraganglioma: DNA methyltransferase inhibitor, Guadecitabine (SGI-110), was tested on wild type GISTs, pheochromocytoma, and paraganglioma associated with SDH deficiency in hereditary leiomyomatosis and renal cell carcinoma (NCT03165721).